Final analysis of a large, open-label global early access protocol (EAP) with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after chemotherapy. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sternberg, Cora N
  • Daugaard, Gedske
  • Geczi, Lajos
  • Hotte, Sebastien
  • Mainwaring, Paul N
  • Saad, Fred
  • Souza, Ciro
  • Tay, Miah Hiang
  • Garrido, Jose Manuel Tello
  • Galli, Luca
  • Londhe, Anil
  • De Porre, Peter
  • Atlan, Dan
  • Goon, Betty
  • Lee, Emma
  • McGowan, Tracy
  • Naini, Vahid
  • Todd, Mary Beth
  • Molina, Arturo
  • George, Daniel J

publication date

  • May 20, 2014